Two Sigma Securities’s Petros Pharmaceuticals PTPI Stock Holding History

Two Sigma Securities’s Portfolio PTPI Stock Details PTPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,454	Closed	-$4.24K	–	1971
2025 Q1	$4.24K	Buy	+2,454	New	+$12.5K	﹤0.01%	1314
2024 Q4	–	Sell	-1,291	Closed	-$11.5K	–	2880
2024 Q3	$11.5K	Sell	1,291 -864	-40%	-$8.1K	﹤0.01%	2570
2024 Q2	$24.6K	Buy	+2,155	New	+$34.6K	﹤0.01%	2664
2022 Q1	–	Sell	-42	Closed	-$35K	–	2428
2021 Q4	$35K	Buy	+42	New	+$24.6K	﹤0.01%	1331

Two Sigma Securities's PTPI Position: Q2 2025 in Review

Two Sigma Securities sold out of Petros Pharmaceuticals (PTPI) in Q2 2025, closing a stake of 2,454 shares — an estimated $4.24K sold.

Two Sigma Securities first reported a position in PTPI in Q4 2021 and held it in 4 quarters. The position peaked at $35K in Q4 2021. 0 funds tracked by Wall St. Rank hold PTPI as of Q2 2025.

Two Sigma Securities reported no remaining Petros Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 2,454 Petros Pharmaceuticals shares in Q2 2025, an estimated $4.24K.
Two Sigma Securities first reported a position in Petros Pharmaceuticals in Q4 2021 and held it in 4 quarters.
Two Sigma Securities's Petros Pharmaceuticals position peaked at $35K in Q4 2021.
0 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.